3. GOOD HEALTH AND WELL-BEING

HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of “Moderate Buy” from Brokerages – Defense World

Written by Amanda

Shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) have been assigned an average recommendation of “Moderate Buy” from the twenty-six analysts that are currently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $257.24.

A number of research firms have weighed in on HCA. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $267.00 to $256.00 in a research report on Tuesday. Jefferies Financial Group cut their target price on shares of HCA Healthcare from $310.00 to $275.00 in a research report on Monday, April 25th. Truist Financial cut their target price on shares of HCA Healthcare from $310.00 to $250.00 and set a “buy” rating for the company in a research report on Monday, April 25th. BMO Capital Markets cut their price objective on shares of HCA Healthcare from $275.00 to $240.00 in a research report on Tuesday, April 26th. Finally, Citigroup cut their price objective on shares of HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a research report on Monday, April 25th.

HCA Healthcare stock opened at $182.33 on Friday. The company’s fifty day simple moving average is $209.33 and its 200-day simple moving average is $236.88. The company has a quick ratio of 1.24, a current ratio of 1.43 and a debt-to-equity ratio of 87.46. HCA Healthcare has a 12 month low of $169.13 and a 12 month high of $279.02. The stock has a market cap of $53.88 billion, a P/E ratio of 8.58, a P/E/G ratio of 1.13 and a beta of 1.61.

HCA Healthcare (NYSE:HCAGet Rating) last posted its quarterly earnings results on Friday, April 22nd. The company reported $4.12 EPS for the quarter, missing the consensus estimate of $4.27 by ($0.15). HCA Healthcare had a net margin of 11.40% and a return on equity of 405.72%. The company had revenue of $14.95 billion for the quarter, compared to analysts’ expectations of $14.72 billion. During the same quarter in the prior year, the firm earned $4.14 earnings per share. The company’s revenue was up 6.9% on a year-over-year basis. On average, equities research analysts expect that HCA Healthcare will post 17.12 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be paid a dividend of $0.56 per share. The ex-dividend date of this dividend is Wednesday, June 15th. This represents a $2.24 annualized dividend and a yield of 1.23%. HCA Healthcare’s dividend payout ratio is 10.54%.

In related news, Director Andrea B. Smith purchased 1,160 shares of the firm’s stock in a transaction dated Thursday, April 28th. The shares were acquired at an average cost of $213.63 per share, with a total value of $247,810.80. Following the completion of the purchase, the director now directly owns 2,239 shares of the company’s stock, valued at $478,317.57. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathleen M. Whalen sold 500 shares of the stock in a transaction that occurred on Tuesday, May 3rd. The shares were sold at an average price of $215.38, for a total transaction of $107,690.00. Following the sale, the senior vice president now directly owns 11,373 shares in the company, valued at $2,449,516.74. The disclosure for this sale can be found here. Insiders have acquired 91,370 shares of company stock worth $19,373,375 over the last ninety days. Insiders own 1.50% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Equitec Proprietary Markets LLC acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $26,000. GoalVest Advisory LLC acquired a new position in HCA Healthcare in the first quarter valued at approximately $26,000. Amplius Wealth Advisors LLC acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $27,000. Wolff Wiese Magana LLC raised its holdings in HCA Healthcare by 1,833.3% in the first quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock worth $29,000 after purchasing an additional 110 shares during the period. Finally, PYA Waltman Capital LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $31,000. Institutional investors and hedge funds own 67.87% of the company’s stock.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Receive News & Ratings for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.

Source: defenseworld.net

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai